Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

China flag China · Delayed Price · Currency is CNY
15.81
-0.34 (-2.11%)
Aug 14, 2025, 2:45 PM CST
-2.11%
Market Cap26.36B
Revenue (ttm)6.35B
Net Income (ttm)-702.49M
Shares Out1.67B
EPS (ttm)-0.42
PE Ration/a
Forward PE21.26
Dividend0.30 (1.85%)
Ex-Dividend DateJul 19, 2024
Volume18,395,753
Average Volume29,993,902
Open16.05
Previous Close16.15
Day's Range15.80 - 16.18
52-Week Range12.41 - 19.82
Beta0.59
RSI49.97
Earnings DateAug 28, 2025

About SHE:002603

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is base... [Read more]

Sector Healthcare
Founded 1992
Employees 11,708
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002603
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.